Acute oral intake of a higenamine-based dietary supplement increases circulating free fatty acids and energy expenditure in human subjects

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Lee, Sang Rok ^a   Schriefer, Johnhenry M ^a   Gunnels, Trint A ^a   Harvey, Innocence C ^a   Bloomer, Richard J ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Fat mobilization; Lipolysis; Nutritional supplements; Thermogenesis; Weight loss

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CAFFEINE; FATTY ACID; GLYCEROL; HIGENAMINE; PLACEBO; RETINOL; YOHIMBINE;

ADULT; AEROBIC EXERCISE; ALCHORNEA; ANAEROBIC EXERCISE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CALORIMETRY; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENERGY EXPENDITURE; FATTY ACID BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; INGESTION; LUNG GAS EXCHANGE; MALE; OXYGEN CONSUMPTION; PAUSINYSTALIA; PHYSICAL ACTIVITY; QUESTIONNAIRE; RAUWOLFIA; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ADULT; ALKALOIDS; BLOOD PRESSURE; BREATH TESTS; CAFFEINE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCEROL; HEALTHY VOLUNTEERS; HEART RATE; HUMANS; LIPOLYSIS; MALE; TETRAHYDROISOQUINOLINES; YOHIMBINE;

EID: 84885779015     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-148     Document Type: Article

References (34)

1. Prevalence of obesity in the United States, 2009-2010. Ogden CL, Carroll MD, Kit BK, Flegal KM, NCHS Data Brief 2012 82 82 1 8 22617494
2. Sedentary behavior and dietary intake in children, adolescents, and adults: a systematic review. Pearson N, Biddle SJ, Am J Prev Med 2011 41 2 178 188 10.1016/j.amepre.2011.05.002 21767726
3. Higher prevalence of obesity in Greek children living in rural areas despite increased levels of physical activity. Tambalis KD, Panagiotakos DB, Kavouras SA, Papoutsakis S, Sidossis LS, J Paediatr Child Health 2013 49 9 769 774 10.1111/jpc.12253 23724863
4. Exercise-inducible factors to activate lipolysis in adipocytes. Hashimoto T, Sato K, Iemitsu M, J Appl Physiol 2013 115 2 260 267 10.1152/japplphysiol. 00427.2013 23681914
5. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL, Int J Obes (Lond) 2006 30 10 1545 1556 10.1038/sj.ijo.0803283 16552410 (Pubitemid 44470204)
6. Effect of one week of fibre supplementation on hunger and satiety ratings and energy intake. Pasman WJ, Saris WH, Wauters MA, Westerterp-Plantenga MS, Appetite 1997 29 1 77 87 10.1006/appe.1997.0091 9268427 (Pubitemid 27397140)
7. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study. Major GC, Doucet E, Jacqmain M, St-Onge M, Bouchard C, Tremblay A, Br J Nutr 2008 99 5 1157 1167 17977472
8. Dietary supplement increases plasma norepinephrine, lipolysis, and metabolic rate in resistance trained men. Bloomer RJ, Fisher-Wellman KH, Hammond KG, Schilling BK, Weber AA, Cole BJ, J Int Soc Sports Nutr 2009 6 10 2783 6-10 10.1186/1550-2783-6-10 19374756
9. Effect of the dietary supplement meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study. Bloomer RJ, Canale RE, Blankenship MM, Hammond KG, Fisher-Wellman KH, Schilling BK, Lipids Health Dis 2009 8 32 511 X-8-32 10.1186/1476-511X-8-32 19656409
10. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Litosch I, Hudson TH, Mills I, Li SY, Fain JN, Mol Pharmacol 1982 22 1 109 115 6289066 (Pubitemid 12097269)
11. Effects of ingestion of a commercially available thermogenic dietary supplement on resting energy expenditure, mood state and cardiovascular measures. Outlaw J, Wilborn C, Smith A, Urbina S, Hayward S, Foster C, Wells S, Wildman R, Taylor L, J Int Soc Sports Nutr 2013 10 1 25 2783 10-25 10.1186/1550-2783-10-25 23627832
12. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Stewart LK, Soileau JL, Ribnicky D, Wang ZQ, Raskin I, Poulev A, Majewski M, Cefalu WT, Gettys TW, Metabolism 2008 57 7 Suppl 1 39 S46 18555853
13. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS, J Nutr 2008 138 9 1677 1683 18716169
14. Coffee consumption is inversely associated with type 2 diabetes in Chinese. Lin WY, Xaiver Pi-Sunyer F, Chen CC, Davidson LE, Liu CS, Li TC, Wu MF, Li CI, Chen W, Lin CC, Eur J Clin Invest 2011 41 6 659 666 10.1111/j.1365-2362. 2010.02455.x 21226707
15. African species of Alchornea; the presence of yohimbine in Alchornea floribunda (Euphorbiaceae). Paris R, Goutarel R, Ann Pharm Fr 1958 16 1 15 20 13571721
16. Yohimbine: a clinical review. Tam SW, Worcel M, Wyllie M, Pharmacol Ther 2001 91 3 215 243 10.1016/S0163-7258(01)00156-5 11744068 (Pubitemid 34017506)
17. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Galitzky J, Taouis M, Berlan M, Riviere D, Garrigues M, Lafontan M, Eur J Clin Invest 1988 18 6 587 594 10.1111/j.1365-2362.1988.tb01272.x 2906290 (Pubitemid 19041524)
18. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Berlan M, Galitzky J, Riviere D, Foureau M, Tran MA, Flores R, Louvet JP, Houin G, Lafontan M, Int J Obes 1991 15 5 305 315 1885256
19. Thermogenic and lipolytic effect of yohimbine in the dog. Galitzky J, Vermorel M, Lafontan M, Montastruc P, Berlan M, Br J Pharmacol 1991 104 2 514 518 10.1111/j.1476-5381.1991.tb12460.x 1797315
20. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Acheson KJ, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C, Tappy L, Am J Clin Nutr 2004 79 1 40 46 14684395 (Pubitemid 41132060)
21. Effects of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fat cells. Butcher RW, Baird CE, Sutherland EW, J Biol Chem 1968 243 8 1705 1712 4384670
22. Oolong tea increases metabolic rate and fat oxidation in men. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, Yamamoto S, Komatsu T, Sawaki T, Ishikura Y, Hosoda K, J Nutr 2001 131 11 2848 2852 11694607 (Pubitemid 33063113)
23. Yohimbine does not affect fat distribution in men. Sax L, Int J Obes 1991 15 9 561 565 1960007
24. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y, Am J Physiol 1995 269 4 Pt 1 671 E678 7485480
25. Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Rudelle S, Ferruzzi MG, Cristiani I, Moulin J, Mace K, Acheson KJ, Tappy L, Obesity (Silver Spring) 2007 15 2 349 355 10.1038/oby.2007.529 17299107 (Pubitemid 46407315)
26. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J, Am J Clin Nutr 1999 70 6 1040 1045 10584049
27. Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking. Corti R, Binggeli C, Sudano I, Spieker L, Hanseler E, Ruschitzka F, Chaplin WF, Luscher TF, Noll G, Circulation 2002 106 23 2935 2940 10.1161/01.CIR. 0000046228.97025.3A 12460875 (Pubitemid 35424745)
28. Caffeine and cardiovascular responses to stress. Lane JD, Psychosom Med 1983 45 5 447 451 6635107 (Pubitemid 13011120)
29. Cardiovascular effects of caffeine in men and women. Hartley TR, Lovallo WR, Whitsett TL, Am J Cardiol 2004 93 8 1022 1026 10.1016/j.amjcard.2003.12.057 15081447 (Pubitemid 38479458)
30. Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Goldstein DS, Grossman E, Listwak S, Folio CJ, Hypertension 1991 18 5 Suppl II40 III48 1657775
31. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Grossman E, Rea RF, Hoffman A, Goldstein DS, Am J Physiol 1991 260 1 Pt 2 142 R147 1847020
32. Effects of higenamine on the cardio-circulatory system. Zhou SJ, Du GY, Zhongguo Zhong Yao Za Zhi 2003 28 10 910 913 15620176
33. A phase I study on pharmacokinetics and pharmacodynamics of higenamine in healthy Chinese subjects. Feng S, Jiang J, Hu P, Zhang JY, Liu T, Zhao Q, Li BL, Acta Pharmacol Sin 2012 33 11 1353 1358 10.1038/aps.2012.114 23085737
34. Acute toxicity of higenamine in mice. Lo CF, Chen CM, Planta Med 1997 63 1 95 96 10.1055/s-2006-957619 9063102 (Pubitemid 27112455)